Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is the most frequent malignancy in children,representing 25–30% of all childhood malignancies. Although treatment outcome has improved owing to advances in chemotherapy, there is still a group of patients who experience severe adverse events. L-Asparaginase is an e...
Main Authors: | Soulaimane M'harzi, Aziza Elouali, Karim Lahrache, Ayad Ghanam, Abdeladim Babakhouya, Maria Rkain, Noufissa Benajiba |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Leukemia Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048922000681 |
Similar Items
-
Corrigendum to Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
by: Aziza Elouali, et al.
Published: (2023-01-01) -
Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol
by: Jian Wang, et al.
Published: (2023-12-01) -
Peg-asparaginase associated toxicities in children with acute lymphoblastic leukemia: A single-center cross-sectional study
by: Sameh Awwad, et al.
Published: (2024-03-01) -
Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment
by: Cristina Díaz-Barriga, et al.
Published: (2021-04-01) -
Asparaginase-Induced Acute Necrotizing Pancreatitis Resulting in Chronic Pancreatitis and Pseudocyst in an Adult with Acute Lymphocytic Leukemia
by: Randy Adiwinata, et al.
Published: (2023-04-01)